GlassScriptPhysician profile
Pankaj Jain
NPI 1730152422
$8,389.46
in general payments reported to CMS, 2019-2025
54 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $1,093 · 2021: $543 · 2022: $1,077 · 2023: $1,667 · 2024: $1,325 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,922 · Debt Forgiveness: $61.64 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,922.23 |
| Debt Forgiveness | $61.64 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,108.58 | 2019 | |
| Intuitive Surgical, INC. | $944.09 | 2023-2024 | Da Vinci Surgical System |
| Caldera Medical, INC | $846.05 | 2020-2021 | |
| Smith+Nephew, INC. | $520.86 | 2019-2025 | Grafix |
| Procept Biorobotics Corporation | $495.12 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $431.53 | 2019-2025 | Erleada, Balversa, Akeega |
| Myriad Genetic Laboratories, INC. | $410.06 | 2020-2024 | Prolaris |
| Astellas Pharma US INC | $409.48 | 2019-2023 | Xtandi, Myrbetriq |
| Izi Medical Products, LLC | $377.42 | 2024 | |
| Pfizer INC. | $342.21 | 2019-2025 | |
| Boston Scientific Corporation | $290.15 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit |
| Coloplast Corp | $148.15 | 2021-2025 | Porges Coloplast, Restorelle |
| Axonics, INC. | $141.63 | 2021-2023 | Axonics, Bulkamid |
| Edwards Lifesciences Corporation | $139.51 | 2024 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $124.86 | 2022 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.